Aspergillosis, the leading fungal cause of mortality in immunocompromised patients, presents a serious worldwide challenge--particularly in the face of increasing antifungal resistance. Bringing together the world's leaders in the Aspergillus and aspergillosis fields to promote cross-disciplinary collaboration among clinicians, industry, and scientific experts, the "Advances Against Aspergillosis" conference was held January 26-28, 2012 in Istanbul, Turkey.
This first of two Annals volumes contains short reviews encapsulating recent clinical findings on aspergillosis. Among the topics included are the application of diagnostic markers to invasive aspergillosis in children, risk stratification for invasive aspergillosis in immunocompromised patients, use of biological agents for the treatment of fungal asthma and allergic bronchopulmonary aspergillosis, immune regulation in idiopathic bronchiectasis, and management of chronic pulmonary aspergillosis.
NOTE: Annals volumes are available for sale as individual books or as a journal. For information on institutional journal subscriptions, please visit: http: //ordering.onlinelibrary.wiley.com/subs.asp?ref=1749-6632&doi=10.111/(ISSN)1749-6632.
ACADEMY MEMBERS: Please contact the New York Academy of Sciences directly to place your order (www.nyas.org). Members of the New York Academy of Science receive full-text access to Annals online and discounts on print volumes. Please visit http: //www.nyas.org/MemberCenter/Join.aspx for more information on becoming a member.
Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.
Karl V Clemons, Stanford University, Stanford, California.
Malcolm Richardson, University of Manchester, Manchester, United Kingdom.
David S Perlin, UMDNJ-New Jersey Medical School, Newark, New Jersey.
Les informations fournies dans la section « A propos du livre » peuvent faire référence à une autre édition de ce titre.
Vendeur : GreatBookPrices, Columbia, MD, Etats-Unis
Etat : New. N° de réf. du vendeur 19066525-n
Quantité disponible : Plus de 20 disponibles
Vendeur : INDOO, Avenel, NJ, Etats-Unis
Etat : New. N° de réf. du vendeur 9781573318549
Quantité disponible : Plus de 20 disponibles
Vendeur : Phatpocket Limited, Waltham Abbey, HERTS, Royaume-Uni
Etat : Like New. Used - Like New. Book is new and unread but may have minor shelf wear. Your purchase helps support Sri Lankan Children's Charity 'The Rainbow Centre'. Our donations to The Rainbow Centre have helped provide an education and a safe haven to hundreds of children who live in appalling conditions. N° de réf. du vendeur Z1-F-057-00812
Quantité disponible : 1 disponible(s)
Vendeur : GreatBookPrices, Columbia, MD, Etats-Unis
Etat : As New. Unread book in perfect condition. N° de réf. du vendeur 19066525
Quantité disponible : Plus de 20 disponibles
Vendeur : GreatBookPricesUK, Woodford Green, Royaume-Uni
Etat : As New. Unread book in perfect condition. N° de réf. du vendeur 19066525
Quantité disponible : 1 disponible(s)
Vendeur : Kennys Bookshop and Art Galleries Ltd., Galway, GY, Irlande
Etat : New. Aspergillosis, the leading fungal cause of mortality in immunocompromised patients, presents a serious worldwide challenge particularly in the face of increasing antifungal resistance. Editor(s): Clemons, Karl V.; Richardson, Malcolm D.; Perlin, David S. Series: Annals of the New York Academy of Sciences. Num Pages: 252 pages, Illustrations. BIC Classification: PSAF; PSG. Category: (P) Professional & Vocational. Dimension: 252 x 177 x 5. Weight in Grams: 226. . 2013. 1st Edition. Paperback. . . . . N° de réf. du vendeur V9781573318549
Quantité disponible : 15 disponible(s)
Vendeur : Ubiquity Trade, Miami, FL, Etats-Unis
Etat : New. Brand new! Please provide a physical shipping address. N° de réf. du vendeur 9781573318549
Quantité disponible : Plus de 20 disponibles
Vendeur : GreatBookPricesUK, Woodford Green, Royaume-Uni
Etat : New. N° de réf. du vendeur 19066525-n
Quantité disponible : 1 disponible(s)
Vendeur : Kennys Bookstore, Olney, MD, Etats-Unis
Etat : New. Aspergillosis, the leading fungal cause of mortality in immunocompromised patients, presents a serious worldwide challenge particularly in the face of increasing antifungal resistance. Editor(s): Clemons, Karl V.; Richardson, Malcolm D.; Perlin, David S. Series: Annals of the New York Academy of Sciences. Num Pages: 252 pages, Illustrations. BIC Classification: PSAF; PSG. Category: (P) Professional & Vocational. Dimension: 252 x 177 x 5. Weight in Grams: 226. . 2013. 1st Edition. Paperback. . . . . Books ship from the US and Ireland. N° de réf. du vendeur V9781573318549
Quantité disponible : 15 disponible(s)
Vendeur : moluna, Greven, Allemagne
Etat : New. Aspergillosis, the leading fungal cause of mortality in immunocompromised patients, presents a serious worldwide challenge particularly in the face of increasing antifungal resistance.KlappentextAspergillosis, the leading fungal ca. N° de réf. du vendeur 596332934
Quantité disponible : Plus de 20 disponibles